Long COVID Research Moonshot Act

Hozzl · 2024-10-23T11:53:16Z

Explore the details of House Bill 9907 Long COVID Research Moonshot Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

10/23/2024, 11:53 AM

Summary of Bill HR 9907

The Long COVID Research Moonshot Act, designated as H.R. 9907 in the 118th Congress, was introduced on October 1, 2024. This bill focuses on addressing the research needs related to Long COVID, a condition that affects individuals long after the initial contraction of COVID-19. Specific provisions and directives within the bill aim to allocate resources, funding, and support for extensive research efforts to better understand and combat the long-term effects of COVID-19. The bill's primary objective is to launch a comprehensive research initiative, or "moonshot," to advance scientific knowledge and responses to Long COVID.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 9907

Bill HR 9907 is currently in the status of Bill Introduced since October 1, 2024. Bill HR 9907 was introduced during Congress 118 and was introduced to the House on October 1, 2024. Bill HR 9907's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of October 1, 2024

Bipartisan Support of Bill HR 9907

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 9907

Primary Policy Focus

Alternate Title(s) of Bill HR 9907

Long COVID Research Moonshot Act

To provide for a comprehensive Federal response to Long COVID, including research, education, and support for affected individuals, to direct the National Institutes of Health to establish a Long COVID research program, and for other purposes.